Table 4.
Nutrition status of participants by demographic and clinical characteristics
| Variables | Description | SGA-A n(%) |
SGA-B n(%) |
SGA-C n(%) |
PVALUE |
|---|---|---|---|---|---|
| PGSGA Score Classification | Reassurance | 78(24) | 3(3.2) | 0(0) | <0.001 |
| Nutrition Education | 57(17.5) | 10(10.8) | 0(0) | ||
| Symptom Management | 120(36.9) | 37(39.8) | 7(13.2) | ||
| Critical Care | 70(21.5) | 43(46.2) | 46(86.8) | ||
| Sex | Male | 67(20.6) | 37(39.8) | 29(54.7) | <0.001 |
| Female | 258(79.4) | 56(60.2) | 24(45.3) | ||
| Cancer Staging | stage 0 | 3(0.9) | 0(0) | 0(0) | 0.002 |
| stage 1 | 46(14.5) | 13(14.8) | 10(19.6) | ||
| stage 2 | 100(31.5) | 16(18.2) | 8(15.7) | ||
| stage 3 | 93(29.3) | 17(19.3) | 14(27.5) | ||
| Stage 4 | 63(19.9) | 33(37.5) | 15(29.4) | ||
| Typeof cancer | Lip, oral cavity and pharynx | 55(16.9) | 23(24.7) | 9(17) | <0.001 |
| Digestive organs | 48(14.8) | 25(26.9) | 26(49.1) | ||
| Respiratory organs | 2(0.6) | 3(3.2) | 2(3.8) | ||
| Bone, cartilage, melanoma | 8(2.5) | 5(5.4) | 3(5.7) | ||
| Breast | 121(37.2) | 15(16.1) | 4(7.5) | ||
| Female genital | 81(24.9) | 20(21.5) | 7(13.2) | ||
| Haematopoietic | 4(1,2) | 2(2.2) | 2(3.8) | ||
| Kaposi sarcoma | 6(1.8) | 0(0) | 0(0) |